Guardion Health Sciences Stock Probability Of Bankruptcy
| GHSIDelisted Stock | USD 3.29 0.04 1.23% |
Guardion |
Guardion Health Sciences Company probability of distress Analysis
Guardion Health's Probability Of Bankruptcy is a relative measure of the likelihood of financial distress. For stocks, the Probability Of Bankruptcy is the normalized value of Z-Score. For funds and ETFs, it is derived from a multi-factor model developed by Macroaxis. The score is used to predict the probability of a firm or a fund experiencing financial distress within the next 24 months. Unlike Z-Score, Probability Of Bankruptcy is the value between 0 and 100, indicating the firm's actual probability it will be financially distressed in the next 2 fiscal years.
More About Probability Of Bankruptcy | All Equity Analysis
Probability Of Bankruptcy | = | Normalized | | Z-Score |
Current Guardion Health Probability Of Bankruptcy | Over 100% |
Most of Guardion Health's fundamental indicators, such as Probability Of Bankruptcy, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Guardion Health Sciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Our calculation of Guardion Health probability of bankruptcy is based on Altman Z-Score and Piotroski F-Score, but not limited to these measures. To be applied to a broader range of industries and markets, we use several other techniques to enhance the accuracy of predicting Guardion Health odds of financial distress. These include financial statement analysis, different types of price predictions, earning estimates, analysis consensus, and basic intrinsic valuation. Please use the options below to get a better understanding of different measures that drive the calculation of Guardion Health Sciences financial health.
The Probability of Bankruptcy SHOULD NOT be confused with the actual chance of a company to file for chapter 7, 11, 12, or 13 bankruptcy protection. Macroaxis simply defines Financial Distress as an operational condition where a company is having difficulty meeting its current financial obligations towards its creditors or delivering on the expectations of its investors. Macroaxis derives these conditions daily from both public financial statements as well as analysis of stock prices reacting to market conditions or economic downturns, including short-term and long-term historical volatility. Other factors taken into account include analysis of liquidity, revenue patterns, R&D expenses, and commitments, as well as public headlines and social sentiment.
CompetitionBased on the latest financial disclosure, Guardion Health Sciences has a Probability Of Bankruptcy of 100%. This is 131.0% higher than that of the Personal Care Products sector and significantly higher than that of the Consumer Staples industry. The probability of bankruptcy for all United States stocks is 151.07% lower than that of the firm.
Guardion Probability Of Bankruptcy Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Guardion Health's direct or indirect competition against its Probability Of Bankruptcy to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Guardion Health could also be used in its relative valuation, which is a method of valuing Guardion Health by comparing valuation metrics of similar companies.Guardion Health is currently under evaluation in probability of bankruptcy category among its peers.
Guardion Fundamentals
| Return On Equity | -0.5 | |||
| Return On Asset | -0.16 | |||
| Profit Margin | 0.52 % | |||
| Operating Margin | (18.75) % | |||
| Current Valuation | (987.33 K) | |||
| Shares Outstanding | 1.35 M | |||
| Shares Owned By Insiders | 1.30 % | |||
| Shares Owned By Institutions | 21.09 % | |||
| Number Of Shares Shorted | 22.26 K | |||
| Price To Earning | (0.71) X | |||
| Price To Book | 0.32 X | |||
| Price To Sales | 0.36 X | |||
| Revenue | 12.25 M | |||
| Gross Profit | 4.52 M | |||
| EBITDA | (3.92 M) | |||
| Net Income | 158.03 K | |||
| Cash And Equivalents | 14.23 M | |||
| Cash Per Share | 0.23 X | |||
| Total Debt | 3.77 M | |||
| Current Ratio | 11.28 X | |||
| Book Value Per Share | 10.71 X | |||
| Cash Flow From Operations | (4.37 M) | |||
| Short Ratio | 0.18 X | |||
| Earnings Per Share | (4.11) X | |||
| Target Price | 40.0 | |||
| Beta | 0.71 | |||
| Market Capitalization | 4.39 M | |||
| Total Asset | 11.92 M | |||
| Retained Earnings | (93.57 M) | |||
| Working Capital | 10.57 M | |||
| Current Asset | 12.8 M | |||
| Current Liabilities | 466.01 K | |||
| Annual Yield | 1.75 % | |||
| Net Asset | 11.92 M |
About Guardion Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Guardion Health Sciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Guardion Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Guardion Health Sciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Other Consideration for investing in Guardion Pink Sheet
If you are still planning to invest in Guardion Health Sciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Guardion Health's history and understand the potential risks before investing.
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum |